CHIRON

Sep 10, 04
16:00 ET	Chiron Announces Settlement with Roche in HIV Patent Dispute
Sep 09, 04
20:24 ET	Chiron Appoints Richard Wills to Board of Directors
Sep 01, 04
08:31 ET	Testing With Procleix(R) West Nile Virus Assay Initiated on Procleix(R) TIGRIS(R) System Under IND
Aug 26, 04
16:45 ET	UPDATE: Chiron Delays Fluvirin(R) Influenza Virus Vaccine Shipments
16:02 ET	Chiron Delays Fluvirin(R) Influenza Virus Vaccine Shipments
Aug 17, 04
07:00 ET	Chiron to Produce Further Pandemic-Like Influenza Vaccines for National Institutes of Health Clinical Studies
Aug 09, 04
08:04 ET	Chiron Foundation Announces 11 More Grant Recipients
Jul 27, 04
08:03 ET	Chiron Names Ursula B. Bartels Vice President and General Counsel
Jul 23, 04
09:24 ET	Chiron Delivers First Million Doses of Fluvirin(R) Influenza Vaccine to U.S. Distributors for Upcoming Influenza Season
Jul 21, 04
16:00 ET	Chiron Reports 2004 Second-Quarter Pro-Forma Results of 25 Cents Per Share
Jul 19, 04
08:30 ET	Pivotal Clinical Trial Begins for Procleix(R) West Nile Virus Blood Screening Assay
Jul 14, 04
16:05 ET	Procleix(R) Ultrio(TM) Study Presented at International Society of Blood Transfusion Conference
Jul 08, 04
08:01 ET	Chiron to Release Earnings on Wednesday, July 21, 2004
Jul 07, 04
05:00 ET	Chiron Receives License for New Meningococcal B Vaccine for New Zealand
Jul 06, 04
08:31 ET	Chiron Acquires Sagres Discovery
Jun 22, 04
02:59 ET	Chiron Grants Nonexclusive HCV License to Prosetta
Jun 17, 04
14:17 ET	Chiron Announces Terms of Convertible Debenture Offering
Jun 16, 04
16:19 ET	Chiron Announces Proposed $350 Million Convertible Debenture Offering
Jun 15, 04
09:01 ET	Chiron Corporation Announces Results of Its Repurchase of Tendered Liquid Yield Option Notes Due 2031
08:01 ET	Chiron Announces June 23 Webcast of Analyst Day
Jun 08, 04
09:01 ET	Chiron Foundation Announces First Grant Recipients
Jun 07, 04
09:00 ET	Chiron Initiates Phase II Study of Low-Dose S.C. Proleukin(R)(Aldesleukin) for Injection Plus Rituximab in Rituximab-Naive Low-Grade NHL Patients
Jun 03, 04
08:02 ET	Chiron to Present at Goldman Sachs Global Healthcare Conference
May 27, 04
15:16 ET	Chiron to Produce Avian Influenza Vaccine for National Institutes of Health Studies
May 20, 04
08:01 ET	Chiron Announces May 27 Webcast of Annual Meeting of Stockholders
May 18, 04
08:02 ET	Chiron Begins Phase III Trial for Tifacogin
May 17, 04
02:01 ET	Chiron Vaccines Spins Out Powder Injection Therapeutic DNA Vaccine Programs to PowderMed Ltd
May 14, 04
08:00 ET	Chiron Corporation Elects to Use Cash to Repurchase Any Tendered Liquid Yield Option Notes Due 2031
May 13, 04
08:00 ET	Chiron to Present at Banc of America Securities Health Care Conference
May 12, 04
08:30 ET	Chiron Receives Sabin Vaccine Institute Global Corporate Philanthropy Award
May 04, 04
08:00 ET	Chiron to Present at Nasdaq Life Sciences Forum
Apr 29, 04
08:02 ET	Chiron to Present at Baird 2004 Growth Stock Conference
Apr 28, 04
08:09 ET	Chiron to Present at Morgan Stanley Global Healthcare Unplugged Conference
Apr 27, 04
11:19 ET	Chiron to Present at Deutsche Bank Securities Health Care Conference
Apr 21, 04
16:00 ET	Chiron Reports 2004 First-Quarter Pro-Forma Results of 22 Cents Per Share
Apr 07, 04
08:30 ET	Chiron to Release Earnings on Wednesday, April 21, 2004
Mar 19, 04
08:31 ET	Chiron Announces Update on Tezacitabine Program
Mar 02, 04
08:05 ET	Chiron to Discuss Plans for Phase III Clinical Development of Tifacogin
08:03 ET	Chiron to Present at the SG Cowen 24th Annual Health Care Conference
Mar 01, 04
07:34 ET	Chiron and XOMA Form Collaboration For Development and Commercialization Of Therapeutic Antibodies For Cancer
Feb 25, 04
08:01 ET	Chiron to Present at Lehman Brothers Seventh Annual Global Healthcare Conference
Feb 17, 04
08:03 ET	Chiron Names Rino Rappuoli, Ph.D., Chief Scientific Officer
Feb 12, 04
08:00 ET	Chiron to Testify to Congress on Influenza Vaccine
Feb 02, 04
08:10 ET	Procleix(R) TIGRIS(R) System Clinical Trials Start With Procleix(R) Ultrio(TM) Assay
Jan 28, 04
16:00 ET	Chiron Reports 2003 Total Revenues of $1.8 Billion
Jan 27, 04
08:01 ET	Chiron to Present at Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference
Jan 22, 04
08:01 ET	Chiron to Present at Piper Jaffray Health Care Conference
Jan 15, 04
19:00 ET	Chiron to Release Earnings on Wednesday, January 28, 2004
08:02 ET	Chiron's HIV Vaccine Candidate Begins Clinical Trial in United States
08:01 ET	Procleix(R) Ultrio(TM) Assay Receives European CE Mark
Jan 14, 04
08:01 ET	Chiron Advances Hepatitis C Vaccine Development Program
Jan 13, 04
08:00 ET	Chiron Vaccines President Selected for GAVI Board
Jan 12, 04
08:04 ET	Chiron Delivers Additional Fluvirin(R) Flu Vaccine Doses to U.S. Department of Health and Human Services
08:04 ET	Chiron Scales Up Production of New Meningococcal B Vaccine for New Zealand
Jan 09, 04
12:25 ET	Chiron Announces Effectiveness of Registration Statement for Resale of 1 5/8% Convertible Debentures Due 2033
Jan 08, 04
08:31 ET	Chiron Provides Update on Program Evaluating Use of Proleukin(R) Interleukin-2 with Monoclonal Antibody
Jan 06, 04
08:31 ET	Chiron to Present at JPMorgan 22nd Annual Healthcare Conference
Jan 05, 04
08:31 ET	Chiron Licenses Technology from Infectio Diagnostic Inc. for Bacterial Detection System for Platelets
08:31 ET	Chiron and ZymeQuest(R) form Partnership for Enzyme Conversion Of Red Blood Cells
Dec 18, 03
08:00 ET	Chiron Grants Nonexclusive HCV License to Boehringer Ingelheim
Dec 11, 03
08:01 ET	Clinical Trials Begin for Procleix(R) Ultrio(TM) Assay
Dec 10, 03
02:00 ET	Procleix(R) Testing Begins in England
Dec 09, 03
16:04 ET	Chiron Increased Fluvirin(R) Influenza Vaccine Production for U.S. Market by Approximately 50 Percent Over 2002-2003 Flu Season
Dec 04, 03
08:00 ET	Chiron to Present at the Harris Nesbitt Gerard Focus on Healthcare Conference 2003
Nov 24, 03
08:32 ET	Chiron Announces Launch of ELITE Trial
Nov 12, 03
16:07 ET	Gen-Probe and Chiron Amend Blood Screening Collaboration Agreement To Set Fixed Revenue Shares
Nov 07, 03
19:15 ET	Chiron Grants Nonexclusive HCV License to Vertex
Nov 06, 03
16:07 ET	Chiron Names David Smith CFO
08:02 ET	Chiron Opens State-of-the-Art Blood Screening Lab in China
Nov 05, 03
08:01 ET	Chiron to Present at Credit Suisse First Boston 2003 Health Care Conference
Nov 03, 03
08:01 ET	Chiron Grants Nonexclusive HCV License to Rigel Pharmaceuticals
00:01 ET	Procleix(R) West Nile Virus Assay Confirmed to Have Detected More Than 800 Infected Blood Donations
Oct 29, 03
16:01 ET	Chiron Reports 2003 Third-Quarter Pro-Forma Income of 60 Cents Per Share
16:01 ET	Chiron to Initiate Phase III Trial for Tifacogin in Patients With Severe Community-Acquired Pneumonia
Oct 28, 03
08:31 ET	Chiron Grants Nonexclusive HCV License to Pfizer
Oct 16, 03
08:04 ET	Chiron Announces Funding of TOBI(R) Foundation Co-Payment Assistance Program
Oct 15, 03
08:02 ET	Chiron to Release Earnings on Wednesday, October 29, 2003
Oct 14, 03
08:01 ET	Chiron Announces Settlement of Patent Dispute Over Roxane Laboratories' Planned Generic Tobramycin Solution for Inhalation
Oct 13, 03
08:01 ET	Betaseron(R) Gains FDA Approval for Pre-Filled Diluent Syringe
Oct 02, 03
19:52 ET	Chiron's Chairman Adopts Rule 10b5-1 Trading Plan
Sep 29, 03
08:06 ET	New Federal Policy Adds Important Cancer Treatment Option
Sep 23, 03
16:34 ET	Chiron Announces Filing of Registration Statement for Resale of 1 5/8% Convertible Debentures Due 2033
08:01 ET	Chiron Announces Filing of Registration Statement for Resale of 1 5/8% Convertible Debentures Due 2033
Sep 16, 03
08:02 ET	Chiron to Present at UBS Global Life Sciences Conference
Sep 15, 03
08:01 ET	Chiron Announces Chairmanship Transition
Aug 28, 03
20:00 ET	Chiron to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference and NewsMakers in the Biotech Industry Conference
Aug 04, 03
08:30 ET	Chiron Grants Nonexclusive HCV License to Gilead Sciences
Jul 31, 03
08:04 ET	Chiron Announces Appointment of Dr. Andrew Heaton to Federal Advisory Committee on Blood Safety
Jul 25, 03
08:01 ET	Chiron Announces Terms of Convertible Debenture Offering
Jul 24, 03
16:16 ET	Chiron Announces Proposed $450 Million Convertible Debenture Offering
Jul 23, 03
16:04 ET	Chiron Reports 2003 Second-Quarter Pro-Forma Income of 35 Cents Per Share
Jul 16, 03
08:05 ET	Chiron Grants HIV and HCV License Agreement to Baxter for Plasma Testing
Jul 09, 03
18:00 ET	Chiron to Release Earnings on Wednesday, July 23, 2003
Jul 08, 03
03:00 ET	Recommended Cash Offer by UBS Investment Bank* on Behalf of Chiron UK-1 Limited a Wholly-Owned Subsidiary of Chiron Corporation and (in the United States) by Chiron UK-1 Limited for PowderJect Pharmaceuticals plc
Jul 07, 03
06:59 ET	Chiron Corporation Announces Resolution of European Commission Inquiry
Jul 03, 03
16:00 ET	Chiron Announces Purchase of PowderJect Shares
07:00 ET	Recommended Cash Offer by UBS Investment Bank* on Behalf of Chiron UK-1 Limited a wholly-owned subsidiary of Chiron Corporation and (in the United States) by Chiron UK-1 Limited for PowderJect Pharmaceuticals plc
Jun 26, 03
08:00 ET	Chiron Announces Expanded BioPharma Leadership
Jun 24, 03
08:01 ET	Recommended Cash Offer by UBS Investment Bank* on Behalf of Chiron UK-1 Limited a wholly-owned subsidiary of Chiron Corporation and (in the United States) by Chiron UK-1 Limited for PowderJect Pharmaceuticals plc
Jun 18, 03
05:00 ET	New Test Developed to Screen Donated Blood for West Nile Virus By July 1 Deadline
Jun 10, 03
08:01 ET	Recommended Cash Offer by UBS Investment Bank* on Behalf of Chiron UK-1 Limited a Wholly-Owned Subsidiary of Chiron Corporation and (in the United States) by Chiron UK-1 Limited for PowderJect Pharmaceuticals plc
Jun 06, 03
16:05 ET	Chiron Announces Purchase of PowderJect Shares
Jun 05, 03
17:05 ET	Chiron to Present at Goldman Sachs 24th Annual Global Healthcare Conference
17:00 ET	Chiron Announces Purchase of PowderJect Shares
Jun 04, 03
09:01 ET	Chiron Announces Expiration of Hart-Scott-Rodino Waiting Period for PowderJect Acquisition
02:00 ET	Chiron Presents Positive TOBI(R) Tobramycin Solution for Inhalation Data At 26th European Cystic Fibrosis Conference
Jun 03, 03
17:00 ET	Chiron Announces Purchase of PowderJect Shares
May 29, 03
17:00 ET	Chiron Announces Purchase of PowderJect Shares
May 28, 03
17:00 ET	Chiron Announces Purchase of PowderJect Shares
May 27, 03
17:00 ET	Chiron Announces Purchase of PowderJect Shares
May 23, 03
17:00 ET	Chiron Announces Purchase of Powderject Shares
May 22, 03
18:32 ET	Chiron Announces Purchase of PowderJect Shares
May 20, 03
19:00 ET	Chiron Announces Purchase of PowderJect Shares
May 19, 03
02:02 ET	Chiron to Acquire PowderJect
02:00 ET	Recommended Cash Offer by UBS Warburg on Behalf of Chiron UK-1 Limited A Wholly-Owned Subsidiary of Chiron Corporation and (in the United States) By Chiron UK-1 Limited for PowderJect Pharmaceuticals plc
May 08, 03
19:33 ET	Chiron Announces May 15 Webcast of Annual Meeting of Shareholders
May 01, 03
08:31 ET	Chiron to Present at Deutsche Bank Securities 28th Annual Health Care Conference
Apr 28, 03
09:01 ET	Chiron to Present at Morgan Stanley Healthcare Unplugged Conference 2003
Apr 25, 03
16:00 ET	Chiron to Present at Nasdaq Life Sciences Forum
Apr 23, 03
16:00 ET	Chiron Reports 2003 First Quarter Pro-Forma Results of 30 Cents Per Share
Apr 22, 03
09:01 ET	Chiron Acquires Exclusive Rights From Novartis for a Therapy Under Evaluation for Treatment of Lung Transplant Acute Rejection
Apr 21, 03
08:30 ET	Chiron Announces Management Change
Apr 16, 03
08:30 ET	Chiron Begins Phase III Trial for Meningococcal C Vaccine
Apr 09, 03
22:00 ET	Chiron to Release Earnings on Wednesday, April 23, 2003
Mar 27, 03
08:31 ET	Chiron Launches Newly Designed Website
Mar 25, 03
07:30 ET	FDA Accepts IND for Procleix(R) West Nile Virus Assay
Mar 20, 03
08:30 ET	Chiron Names Howard Pien Chief Executive Officer
Mar 19, 03
18:00 ET	Chiron to Present at the Banc of America Securities Healthcare Conference
Mar 13, 03
08:30 ET	Chiron Granted U.S. HIV Patent
Mar 12, 03
18:00 ET	Chiron to Present at the SG Cowen Health Care Conference
Feb 27, 03
08:30 ET	Chiron to Initiate Phase III Trial in U.S. for Meningococcal C Vaccine
Feb 25, 03
18:00 ET	Chiron to Present at the Lehman Brothers Global Healthcare Conference
Feb 19, 03
18:00 ET	Chiron to Present at the BIO CEO and Investor Conference 2003
Feb 10, 03
18:00 ET	Chiron Appoints J. Richard Fredericks to Board of Directors
Jan 29, 03
16:01 ET	Chiron Reports 2002 Total Revenues of $1.3 Billion
06:20 ET	Chiron to Present at The Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Jan 22, 03
16:06 ET	Chiron to Present at the U.S. Bancorp Piper Jaffray Health Care Conference
Jan 15, 03
06:20 ET	Chiron to Release Earnings on Wednesday, January 29, 2003
Jan 14, 03
17:13 ET	Chiron Corporation and SILCAAT Principal Investigators Agree on Transfer of Trial
Jan 08, 03
09:20 ET	Chiron Partners With GlaxoSmithKline for Obesity Drug Program
Dec 31, 02
09:20 ET	Chiron to Present at the JPMorgan H&Q 21st Annual Healthcare Conference
Nov 19, 02
08:30 ET	Chiron Signs Multi-Year Agreements with U.S Blood Collection Organizations
Nov 06, 02
16:01 ET	Chiron to Present at the Credit Suisse First Boston Healthcare Conference And the SG Cowen 4th Annual Global Health Care Conference
Oct 24, 02
16:03 ET	Chiron to Present at Salomon Smith Barney 2002 Health Care Conference
Oct 23, 02
16:00 ET	Chiron Corporation Provides Clinical Pipeline Update
16:00 ET	Chiron Reports 2002 Third Quarter Pro-Forma Results of 46 Cents Per Share
Oct 14, 02
08:32 ET	Chiron Announces Financial Results For Third Quarter Expected to Exceed Expectations
Oct 09, 02
17:00 ET	Chiron to Release Earnings on Wednesday, October 23, 2002
Oct 01, 02
20:00 ET	Chiron to Present at UBS Warburg Global Life Sciences Conference
Sep 24, 02
08:31 ET	Chiron Appoints Denise O'Leary to Board Of Directors
Sep 12, 02
16:15 ET	Chiron to Present at Bear Stearns 15th Annual Healthcare Conference
Aug 22, 02
08:30 ET	Chiron Appoints Jack Goldstein President, Chiron Blood Testing
Aug 06, 02
08:31 ET	Chiron Corporation Donates 9.5 Million Vaccine Doses to Polio Global Eradication Initiative
Jul 24, 02
16:00 ET	Chiron Reports 2002 Second Quarter Pro-Forma Results of 29 Cents Per Share
Jul 10, 02
20:29 ET	Chiron to Release Earnings on Wednesday, July 24, 2002
08:30 ET	Chiron Grants Non-Exclusive HCV License to Abbott Laboratories
Jun 20, 02
16:30 ET	Chiron to Present at Nasdaq 100 Investors' Conference
08:30 ET	Chiron Corporation and Ortho-Clinical Diagnostics Announce Sponsorship of PBS Documentary 'Red Gold: The Epic Story of Blood'
Jun 19, 02
08:30 ET	Chiron Grants Non-Exclusive HCV License to Merck & Co., Inc.
Jun 06, 02
08:01 ET	Chiron to Present at Goldman Sachs & Co. 23rd Annual Global Healthcare Conference
May 16, 02
09:17 ET	Chiron Corporation Announces Its Annual Meeting of Shareholders Conference Call on the Web; Live and Archived Conference Call Notification
May 10, 02
09:17 ET	Chiron Corporation Announces Its Annual Meeting of Shareholders Conference Call on the Web; Live and Archived Conference Call Notification
May 03, 02
13:09 ET	Chiron to Present at Deutsche Banc Securities Health Care Conference
Apr 24, 02
16:02 ET	Chiron Reports 2002 First Quarter Pro-Forma Results of 21 Cents Per Share
Apr 23, 02
09:00 ET	Chiron Appoints William G. Green as President, Chiron Blood Testing
Apr 10, 02
19:59 ET	Chiron to Release Earnings on Wednesday, April 24, 2002
Mar 29, 02
16:38 ET	Chiron Corporation Completes Acquisition of Matrix Pharmaceutical, Inc.
Feb 28, 02
10:04 ET	Chiron's Procleix(TM) HIV-1/HCV Assay Receives FDA Approval
Feb 19, 02
23:07 ET	Chiron Corporation Successfully Completes Cash Tender Offer For Shares of Matrix Pharmaceutical, Inc.
Feb 11, 02
21:00 ET	Chiron and Matrix Announce Extension of Tender Offer
Feb 01, 02
13:26 ET	Chiron Corporation and Global Alliance for TB Drug Development
Jan 30, 02
16:00 ET	Chiron Reports Total Revenues Exceed $1 Billion in 2001
Jan 29, 02
16:38 ET	Chiron to Present at the Piper Jaffray Health Care Conference and the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
16:37 ET	Chiron and Matrix Announce Early Termination of Hart-Scott-Rodino Waiting Period
Jan 16, 02
20:13 ET	Chiron to Release Earnings on Wednesday, January 30, 2002
Jan 15, 02
12:37 ET	FDA Approves First Room-Temperature MS Treatment Option
Jan 08, 02
10:38 ET	Chiron to Present at JPMorgan 20th Annual Health Care Conference
Jan 07, 02
07:01 ET	Chiron Corporation to Acquire Matrix Pharmaceutical
Dec 04, 01
18:25 ET	Chiron Corporation and Inhale Announce Collaborations to Develop Inhaled Tobramycin and Other Antibiotics
Nov 27, 01
08:30 ET	Chiron Grants Non-Exclusive HCV License to Bristol-Myers Squibb Company
Nov 21, 01
07:00 ET	Chiron Announces Results of Phase III Study of Tifacogin in Severe Sepsis
Oct 29, 01
16:01 ET	Chiron to Present at Salomon Smith Barney 2001 Health Care Conference
Oct 24, 01
16:00 ET	Chiron Reports 2001 Third Quarter Pro-Forma Results of 30 Cents Per Share
Oct 10, 01
16:37 ET	Chiron to Release Earnings on Wednesday, October 24, 2001
Sep 19, 01
19:00 ET	Chiron Corporation Announces Form S-3 From LYONS Offering Is Declared Effective
Aug 08, 01
07:01 ET	Chiron Appoints Craig A. Wheeler as President, Chiron BioPharmaceuticals
Jul 25, 01
22:38 ET	Chiron Corrects Omission on Condensed Consolidated Statements of Operations
16:01 ET	Chiron Reports 2001 Second Quarter Pro-Forma Results of 21 Cents Per Share
Jul 17, 01
16:31 ET	Menjugate (TM), Chiron's Meningococcal C Vaccine, Chosen for Quebec Vaccination Program
Jul 11, 01
16:19 ET	Chiron to Release Earnings on Wednesday, July 25, 2001
Jun 20, 01
07:31 ET	Ribozyme and Chiron Commence Phase II ANGIOZYME(TM) Colorectal Cancer Trial
Jun 14, 01
19:08 ET	Bayer Acquires Certain Rights to Infectious Disease Diagnostics From Ortho-Clinical Diagnostics and Chiron Corporation
Jun 12, 01
19:54 ET	Chiron to Present at Goldman Sachs 22nd Annual Healthcare Conference
Jun 07, 01
10:21 ET	Chiron Corporation to Receive $400 Million From Offering of LYONS
Jun 06, 01
17:25 ET	Chiron Corporation to Raise $400 Million From Offering of LYONs
May 23, 01
01:00 ET	Chiron Licenses Its HIV-1 and HCV Intellectual Property for NAT Blood Screening to Roche
May 14, 01
21:00 ET	Chiron Corporation Annual Meeting of Stockholders Broadcast Live on the Web
May 07, 01
21:00 ET	Chiron to Present at Deutsche Banc Alex. Brown's 26th Annual Health Care 2001 Conference
May 03, 01
07:30 ET	Chiron and Rhein Biotech Form Collaboration to Develop Combination Pediatric Vaccines
Apr 25, 01
16:02 ET	Chiron Reports 2001 First Quarter Pro-Forma Results of 19 Cents Per Share
08:31 ET	Chiron's Meningococcal C Vaccine Approved in Canada
Apr 16, 01
05:30 ET	Chiron to Release Earnings on Wednesday, April 25, 2001
Mar 15, 01
07:01 ET	Chiron to Present at American College of Cardiology Conference
07:01 ET	Chiron to Present at the SG Cowen 21st Annual Healthcare Conference
Mar 13, 01
07:00 ET	Chiron Announces Increase in Stock Repurchase Program
Mar 12, 01
07:01 ET	The BLA for the Chiron Procleix(TM) HIV-1/HCV Assay Accepted for Review By the FDA
Mar 07, 01
07:00 ET	Chiron Grants Non-Exclusive HCV License to Japan Tobacco, Inc.
Mar 02, 01
02:00 ET	SkyePharma and Chiron Announce Re-Launch of DepoCyt(R)
Feb 22, 01
00:05 ET	Chiron Appoints John A. Lambert as President, Chiron Vaccines
Feb 02, 01
07:30 ET	Chiron Grants Non-Exclusive HCV License to The R. W. Johnson Pharmaceutical Research Institute
Jan 31, 01
23:00 ET	Chiron to Present at the Merrill Lynch Global Pharmaceutical, Medical Device & Biotechnology Conference
Jan 30, 01
16:00 ET	Chiron Reports Solid 2000 Results
Jan 28, 01
18:49 ET	Chiron HIV Patent Upheld in Europe
Jan 27, 01
12:57 ET	Chiron Announces Results of FGF-2 Phase II Clinical Trial in Peripheral Artery Disease
Jan 26, 01
16:15 ET	Chiron to Present FGF-2 Data at American Heart Association Angiogenesis Conference
Jan 25, 01
20:00 ET	Chiron to Present at U.S. Bancorp Piper Jaffray Health Care Conference
20:00 ET	Chiron to Present at U.S. Bancorp Piper Jaffray Health Care Conference
Jan 18, 01
17:00 ET	Chiron Grants Organon Teknika License to HIV Assay Patents
17:00 ET	Chiron to Release Earnings on Tuesday, January 30, 2001
Jan 08, 01
07:33 ET	Chiron Divests Gene Therapy Manufacturing Facilty to Cell Genesys
Jan 05, 01
23:21 ET	Chiron to Present at Chase H&Q Medical Conference
Nov 22, 00
23:17 ET	Chiron to Present at SG Cowen Global Healthcare Conference
23:09 ET	Chiron to Present at Robertson Stephens Medical Conference
Nov 14, 00
20:00 ET	Chiron to Present at Credit Suisse First Boston Healthcare Conference
Oct 31, 00
12:00 ET	Chiron to Hold Business Review Webcast on Monday, November 6, 2000
Oct 25, 00
16:01 ET	Chiron Reports 2000 Third Quarter Results of 23 Cents per Share
Oct 17, 00
18:57 ET	Chiron to Release Earnings on Wednesday October 25, 2000
01:00 ET	The UK and Ireland Health Authorities Approve Menjugate(TM) for Infant Use
Oct 11, 00
03:18 ET	Chiron and Roche Agree to Major Diagnostic Licensing Terms
Sep 22, 00
09:00 ET	Chiron Corporation Completes Acquisition of PathoGenesis Corporation
Sep 19, 00
09:01 ET	Chiron Corporation Successfully Completes Cash Tender Offer For Shares of Pathogenesis Corporation
Sep 18, 00
08:05 ET	Chiron Hepatitis C Research Honored with 2000 Lasker Award for Clinical Medical Research
Sep 08, 00
17:30 ET	Chiron Calls for Redemption of 1.90 Percent Convertible Bond
Aug 31, 00
08:31 ET	Chiron and Pathogenesis Announce Early Termination of Hart-Scott-Rodino Waiting Period and Completion of Regulatory Filings for Pathogenesis Acquisition
Aug 14, 00
04:42 ET	Chiron to Acquire PathoGenesis
04:39 ET	Chiron to Acquire PathoGenesis for $38.50 Per Share
Aug 08, 00
16:30 ET	Chiron's Menjugate(TM) Cleared by Ireland Health Authorities
Aug 02, 00
16:01 ET	Chiron Reports 2000 Second Quarter Results of 30 Cents Per Share
Jul 25, 00
00:01 ET	Chiron Concludes rhIGF-I Osteoarthritis Clinical Development Program
Jul 14, 00
08:00 ET	Chiron Enters Co-Marketing and Co-Promotion Agreement With Aventis Pasteur MSD For Menjugate(TM), Fluad(TM)
Jul 08, 00
05:00 ET	Phase II Results Show Significant Increase in CD4 Counts Without Producing A Sustained Increase in Viral Load Levels in HIV-Infected Patients Receiving rhIL-2
Jul 07, 00
05:00 ET	Chiron Durable Response Data for Proleukin(R) Approved by the FDA
Jul 02, 00
17:44 ET	Chiron Patent for HCV Nucleic Acid Testing Upheld in Europe
Jun 27, 00
12:00 ET	Chiron Awarded NIH Contract to Develop HIV Vaccine
Jun 08, 00
05:00 ET	Chiron Files Patent Infringement Action Against Genentech
Jun 07, 00
08:02 ET	Chiron Announces Stock Repurchase Program
Jun 01, 00
22:30 ET	Chiron and PharmBio Growth Fund Form Singapore-Based Drug Discovery Venture S*BIO
May 25, 00
03:05 ET	Chiron Corporation and The National Institute of Public Health of Norway Signing Ceremony Initiates Meningitis Vaccine Development Agreement
May 24, 00
03:05 ET	European Mutual Recognition Approval of Chiron's Influenza Vaccine Fluad(R) Enables Launch By 2000-2001 Flu Season
May 19, 00
08:01 ET	Chiron Defeats Roche in German HIV Patent Infringement Suit
May 15, 00
19:02 ET	Chiron Elects Not to Proceed With Convertible Bond Exchange Offer
May 10, 00
18:05 ET	Chiron Share Price Average Announced as Required Under the Convertible Bond Exchange Offer
May 03, 00
14:00 ET	Chiron Reports 2000 First Quarter Results
Apr 17, 00
15:53 ET	Chiron Calls for Redemption of 5.25 Percent Convertible Bond
15:45 ET	Chiron Commences Its Previously Announced Bond Exchange Offer
Apr 14, 00
01:10 ET	Chiron Grants Glaxo Wellcome Non-Exclusive HCV License
Apr 06, 00
18:07 ET	Chiron Plans to Conduct Exchange Offer With Holders of Its Existing 1.90% Convertible Subordinated Notes
Mar 20, 00
16:42 ET	Chiron Enjoins Sorin From Producing or Marketing HCV Diagnostic in Italy
Mar 12, 00
12:00 ET	Chiron Announces Preliminary Findings From Phase II Clinical Trial of FGF-2
Mar 09, 00
16:00 ET	Chiron Reports on Discovery of Novel Men B Vaccine Candidates Based on Whole Genome Sequencing of Neisseria Meningitidis by TIGR
Mar 07, 00
17:00 ET	Chiron Announces Stock Repurchase Program
Mar 06, 00
18:54 ET	Chiron Granted Hepatitis C Patent
Mar 01, 00
18:52 ET	Chiron's Meningitis C Vaccine Approved in UK
Feb 29, 00
18:51 ET	Chiron Granted Broad Patents Covering Novel Vaccine Technology
Feb 08, 00
18:49 ET	Chiron Reports Full-Year 1999 Results
Jan 13, 00
18:48 ET	Chiron Appoints Dr. Andrew Heaton as Vice President and Chief of Operations For Blood Testing